Securities code: 000952 securities abbreviation: Hubei Guangji Pharmaceutical Co.Ltd(000952) Announcement No.: 2022-010 Hubei Guangji Pharmaceutical Co.Ltd(000952)
Insider information about the restricted stock incentive plan in 2021 and
Self inspection report on the purchase and sale of company shares by incentive objects
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hubei Guangji Pharmaceutical Co.Ltd(000952) (hereinafter referred to as ” Hubei Guangji Pharmaceutical Co.Ltd(000952) ” and “the company”) convened the 10th (Interim) meeting of the 10th board of directors and the 9th (Interim) meeting of the 10th board of supervisors on November 12, 2021 to consider and adopt the proposal on Hubei Guangji Pharmaceutical Co.Ltd(000952) 2021 restricted stock incentive plan (Draft) and its summary Proposals related to equity incentive, such as the proposal on the measures for the administration of the implementation and assessment of the Hubei Guangji Pharmaceutical Co.Ltd(000952) 2021 restricted stock incentive plan, are detailed in the company’s designated information disclosure media and cninfo.com on November 13, 2021（ http://www.cn.info.com.cn. ）Relevant announcements of disclosure.
In accordance with the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), the measures for the administration of information disclosure of listed companies, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – business handling and other laws and regulations and the relevant provisions of the articles of association, The company has taken sufficient and necessary confidentiality measures for the 2021 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) and registered the insiders of the incentive plan. Through the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to as “CSDCC”), the company inquired about the insider information of the incentive plan and the trading of the company’s shares within 6 months before the public disclosure of the incentive plan (i.e. May 12, 2021 to November 12, 2021, hereinafter referred to as the “self inspection period”), The specific circumstances are as follows: first, the scope and procedures of verification
1. The verification object is the insider and incentive object of the incentive plan (hereinafter referred to as the “verification object”).
2. The insiders of the incentive plan filled in the registration form of insiders. 3. The company inquired with CSDCC about the purchase and sale of the company’s shares during the self inspection period, and China Securities Registration Company issued the inquiry certificate of shareholding and share change of information disclosure obligor and the detailed list of shareholder share change.
2、 Description of the purchase and sale of the company’s shares by the verification object during the self inspection period
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued by China Clearing on November 18, 2021, the verification objects’ purchase and sale of the company’s shares during the self inspection period are as follows:
1. Insider
Serial number name position self inspection period cumulative purchase self inspection period cumulative number of company shares sold (shares) company shares (shares)
1 Yang Xin ordinary staff 12500
2. Incentive objects of this incentive plan
Serial number name position self inspection period cumulative purchase self inspection period cumulative number of company shares sold (shares) company shares (shares)
1 pay 3000 5000 for middle-level cadres forever
2 Hong Guoyuan middle-level cadre 3200
3 Guo Linsheng core technical / business personnel 900 4900
4 Wang Xin’s core technical / business personnel 6700 1500
5 to Liuqing core technical / business personnel 15000 0
6 Jiang Zhonglin core technical / business personnel 5100
7 Yang Chun’s core technical / business personnel 700
8 Chen Xipeng core technology / business personnel 100
9 Chen Song core technology / business personnel 0 100
Verified by the company:
1. Description of insider trading company shares
During the self-examination, one insider traded stocks. The trading behavior of the above-mentioned personnel occurred before they were listed as insiders of inside information. They did not know any information about the incentive plan at that time. The trading changes during the verification period were based on their own independent judgment of the trading situation in the secondary market, and there was no situation of insider trading due to knowing the inside information.
2. Description of the incentive object’s purchase and sale of the company’s shares
During the self-examination, a total of 9 incentive objects had stock trading behavior. The stock trading of the above incentive objects during the self-examination was based on their independent judgment of the trading situation in the secondary market. They did not know the specific scheme elements and other relevant information of the incentive plan before buying and selling the company’s shares, Neither did the insider know the inside information of the company’s incentive plan through the insider, and there was no case of using the inside information related to the incentive plan for stock trading.
3、 Self inspection conclusion
Before the announcement of this incentive plan, the company limited the scope of personnel involved in the planning and discussion in strict accordance with the management measures, the registration and filing system for insiders of inside information and the relevant internal confidentiality system of the company, registered the relevant company personnel and intermediaries exposed to inside information in time, and took corresponding confidentiality measures. Within 6 months before the company’s first public disclosure of the draft incentive plan, no disclosure of inside information was found, and no insider and incentive object traded the company’s shares for profit through inside information. 4、 Documents for future reference
1. Inquiry certificate of shareholding and share change of information disclosure obligor issued by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch;
2. Detailed list of changes in shareholders’ shares issued by Shenzhen Branch of China Securities Depository and Clearing Corporation.
It is hereby announced.
Hubei Guangji Pharmaceutical Co.Ltd(000952) board of directors February 8, 2022
